Bristol-Myers Squibb Company manufactures, markets and/or distributes more than 36 drugs in the United States.
Drugs Associated with Bristol-Myers Squibb Company.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
| Sustiva Generic name: efavirenz Drug class: NNRTIs | 6 reviews | 5.2 / 10 |
What drugs does Bristol Myers Squibb make?
Our medicines
- ABECMA® (idecabtagene vicleucel)
- ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)
- AZACTAM® (aztreonam for injection, USP)
- BREYANZI® (lisocabtagene maraleucel)
- BARACLUDE® (entecavir)
- CAMZYOSTM (mavacamten)
- DROXIA® (hydroxyurea)
- ELIQUIS® (apixaban)
What does BMS produce?
Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.
How large is Bristol Myers Squibb?
Bristol-Myers Squibb (BMS) is one of the largest pharmaceutical companies in the world, with 25,000 employees and $19.4 billion in revenue in 2016.
Is Bristol Myers part of Pfizer?
About the Bristol-Myers Squibb/Pfizer Collaboration
This global alliance combines Bristol-Myers Squibb’s long-standing strengths in cardiovascular drug development and commercialization with Pfizer’s global scale and expertise in this field.
Who makes Eliquis drug?
Brand Name: Eliquis® Generic Name: apixaban Manufacturer: Bristol-Myers Squibb Co. with nonvalvular atrial fibrillation.
Is Bristol-Myers Squibb an ethical company?
We take seriously our responsibility for the ethical treatment of animals used in research. Our mission to discover, develop and deliver innovative medicines has both a legal and ethical obligation to ensure their safety and efficacy prior to use in humans.
Where does BMS rank in the top pharmaceutical companies?
Rank: 9
- 2021 Revenues ($USD) : $46,385,000,000.
- 2021 R&D spend : $11,354,000,000.
- 2021 Number of Employees : 32,200.
- Fiscal Year End : 12/31/2021.
- Leader : CEO Giovanni Caforio.
What makes BMS unique?
Bristol Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm.
Is BMS a Fortune 500 company?
Bristol-Myers Squibb | 2022 Fortune 500 | Fortune.
Does Bristol Myers Squibb pay well?
Bristol-Myers Squibb Company pays its employees an average of $103,542 a year. Salaries at Bristol-Myers Squibb Company range from an average of $66,386 to $163,172 a year.
How does Bristol Myers Squibb make money?
Key Points. Bristol-Myers has multiple top-selling drugs in its portfolio that generate billions in revenue. The company is a money-making machine that could bring in $50 billion in free cash over the next few years. Its low valuation and high dividend yield make it an all-around safe stock to just buy and hold.
Should I invest in Bristol Myers Squibb?
Valuation metrics show that Bristol Myers Squibb Company may be undervalued. Its Value Score of A indicates it would be a good pick for value investors. The financial health and growth prospects of BMY, demonstrate its potential to outperform the market. It currently has a Growth Score of C.
Is Pfizer still owned by Johnson and Johnson?
In 2006, Johnson & Johnson acquired Pfizer’s consumer healthcare business and merged it with its consumer healthcare business group. The acquisition added brands like Listerine, Bengay, and Neosporin to the company’s portfolio.
Who took over Pfizer?
Michael Goettler, currently Pfizer’s Upjohn chief, will take the helm as CEO. The two parties are looking at a stock transaction, in which Mylan investors will get 43% of the combined company and Pfizer investors the rest.
Is Moderna or Pfizer the same?
Moderna uses the same mRNA technology as Pfizer-BioNTech and had a similarly high efficacy at preventing symptomatic disease when the companies applied for authorization; it also needs to be stored in freezer-level temperatures.
What drug is as good as Eliquis?
Pradaxa, Xarelto, Savaysa, Warfarin, and Heparin are some Eliquis alternatives.
Does Pfizer own Eliquis?
Blood thinner Eliquis has been a major growth driver for Bristol-Myers Squibb and partner Pfizer, as well as the overall biopharma sector. Now, though, the blockbuster earner might face some cheaper company. The FDA approved the first two copycats to Eliquis, made by Mylan and Micro Labs, on Christmas Eve.
Is Eliquis being recalled?
No. There is sufficient supply of Eliquis on the market to meet patient demand.
Who purchased Bristol Myers Squibb?
LOTTE Group
LOTTE Group is in over 30 countries around the world.
Does Berkshire Hathaway own Bristol Myers Squibb?
During that time, Berkshire snapped up shares in Merck, Pfizer, AbbVie and BMS that were valued at $5.66 billion at the time. The latest 13F shows that the company is no longer holding any of those stocks. Even Biogen found itself on Buffet’s radar, as Berkshire once owned a roughly $192 million stake.